文献速递哮喘慢阻肺

哮喘-慢阻肺重叠综合征与成人起病哮喘的差异

Differences between asthma-COPD overlap syndrome and adult-onset asthma.
PubMed 文献 · Eur Respir J · 2017-05-01

基于Seinäjoki成人哮喘研究(SAAS)队列,188例成人起病哮喘患者诊断后12年复评,按吸烟史和支气管舒张后肺功能分为三组。ACOS患者较非ACOS组弥散功能更低、血中性粒细胞和IL-6更高,肺功能更差、支气管可逆性更高且合并症更多。

要点

  • ACOS患者DLCO/VA低于无吸烟史及非阻塞性吸烟患者。
  • ACOS患者血中性粒细胞及IL-6水平高于其他两组。
  • ACOS患者肺功能更差、剩余支气管可逆性更高、合并症更多。

核心结论

  • ACOS与成人起病哮喘在弥散功能、血中性粒细胞、IL-6、支气管可逆性、肺功能和合并症方面存在明显差异。

研究设计与样本

  • SAAS临床队列研究,188例成人起病哮喘患者诊断后12年复评,按吸烟史和支气管舒张后肺功能分为三组。

主要发现

  • ACOS患者DLCO/VA为86%预计值,低于<10包年非吸烟/戒烟组的98%和非阻塞性≥10包年组的96%(p<0.001)。
  • ACOS患者血中性粒细胞为4.50×10^9 L-1,高于其他两组的3.60或3.85×10^9 L-1(p=0.008)。
  • ACOS患者IL-6为2.88 pg·mL-1,高于其他两组的1.52或2.10 pg·mL-1(p<0.001)。
  • ACOS患者肺功能更低、剩余支气管可逆性更高、合并症数量更多。

临床怎么用

  • 成人哮喘综合评估时应关注弥散功能、血中性粒细胞、IL-6、支气管可逆性及合并症,以识别ACOS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Differences between asthma-COPD overlap syndrome (ACOS) and adult-onset asthma are poorly understood. This study aimed to evaluate these differences in a clinical cohort of patients with adult-onset asthma, as a part of the Seinäjoki Adult Asthma Study (SAAS).188 patients were diagnosed with adult-onset asthma and re-evaluated 12 years after diagnosis. They were divided into three groups based on smoking history and post bronchodilator spirometry values: 1) never- and ex-smokers with <10 smoked pack-years; 2) non-obstructive (forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ≥0.7) patients with ≥10 pack-years; and 3) ACOS patients with ≥10 pack-years and FEV1/FVC <0.7.ACOS patients had lower diffusing capacity (DLCO/VA 86% predicted versus 98 or 96% predicted; p<0.001), higher blood neutrophil levels (4.50 versus 3.60 or 3.85×109 L-1; p=0.008), and higher IL-6 levels (2.88 versus 1.52 or 2.10 pg·mL-1, p<0.001) as compared to never- and ex-smokers with <10 pack-years, or non-obstructive patients with ≥10 pack-years smoking history, respectively. ACOS patients also showed reduced lung function, higher remaining bronchial reversibility and a higher number of comorbidities.This study shows distinct differences in diffusing capacity, blood neutrophil and IL-6 levels, bronchial reversibility, lung function and comorbidities between ACOS and adult-onset asthma. The present findings should be considered in the comprehensive assessment of adult asthma patients.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Tommola M, Ilmarinen P, Tuomisto LE, et al. Differences between asthma-COPD overlap syndrome and adult-onset asthma. Eur Respir J. 2017. PMID: 28461298. doi:10.1183/13993003.02383-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。